Portfolio company
CEVEC
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company produces human cell-based expression systems and viral vector manufacturing technologies for biopharmaceutical firms and biotechnology organisations developing therapeutic proteins and gene therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GenVec
This clinical-stage biotechnology company develops gene-based therapeutics and vaccines using a proprietary delivery platform for the biopharmaceutical industry.
Salve Therapeutics
The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.
SIRION Biotech
The company develops and manufactures viral vector technologies for researchers and pharmaceutical firms in the cell and gene therapy sectors.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
Cellevate
This company develops nanofiber cell culture microcarriers for biopharmaceutical manufacturers to enhance viral vaccine and gene therapy production yields.
CePep AB
This company develops cell-penetrating peptide delivery platforms for nucleic acid based therapeutics and drug discovery applications within the biotechnology and pharmaceutical industries.
Forge Biologics
This company provides adeno-associated virus manufacturing services and develops gene therapies for biotechnology and pharmaceutical organisations.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
